Drugs / PCV-LITE
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06986239 | Jul 2025 → Apr 2026 overdue | — | LiteVax BV | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PCV-LITE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06986239 ↗ |
| Modality | Vaccine | “Pneumococcal Conjugate Vaccine” NCT06986239 ↗ |
| Route | Intramuscular | “A single intramuscular injection of 0.5 mL comprising 1/5th dose of Prevenar20 without LiteVax Adjuvant (LVA)” NCT06986239 ↗ |